IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims Against Sunesis Pharmaceuticals, Inc. on Behal...
July 24 2015 - 5:17PM
Business Wire
Goldberg Law PC (http://www.Goldberglawpc.com) announces that it
is investigating claims of potential misrepresentations by Sunesis
Pharmaceuticals, Inc. (“Sunesis” or the “Company”) (NASDAQ: SNSS).
The investigation focuses on whether the Company and its officers
violated securities laws by issuing misleading information to
investors.
If you purchased or otherwise acquired Sunesis shares and would
like more information regarding the investigation, we advise you to
contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650
Marina Pointe Dr. Suite 1404, Marina Del Rey, CA 90292, at
800-977-7401, to discuss your rights without cost to you. You can
also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
The investigation concerns whether the Company and certain of
its officers and/or directors have violated Sections 10(b) and
20(a) of the Securities Exchange Act of 1934. Specifically, the
investigation will focus on the Company’s July 23, 2015,
announcement that the United States Food and Drug Administration
(“FDA”) will not approve its blood cancer drug Qinprezo. When this
news reached the investing public, shares of Sunesis fell more than
70% causing investors harm.
If you have any questions concerning your legal rights in this
case, please immediately contact Goldberg Law PC at 800-977-7401,
or visit our website at http://www.Goldberglawpc.com, or email us
at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150724005887/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.
800-977-7401Brian Schall, Esq.
800-977-7401info@goldberglawpc.comhttp://www.Goldberglawpc.comhttps://twitter.com/search?q=golberglawpc&src=typdhttps://www.facebook.com/pages/Goldberg-Law-PC/850505465033804?fref=ts
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024
Real-Time news about Sunesis Pharmaceuticals Inc (NASDAQ): 0 recent articles
More Sunesis Pharmaceuticals, Inc. (MM) News Articles